Sigyn Therapeutics, Inc. (SIGY): EPS (Diluted)

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-40, first reflected in a filing dated 2024-02-20. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

-$2.51
Year ended 2024-12-31
2022-12-31: -$3.132023-12-31: -$3.772024-12-31: -$2.51-$2.51
2022-12-31 EPS (Diluted) (USD per share) 2024-12-31
Period endedEPS (Diluted)Change YoYSource filing
2024-12-31-$2.51n/m2025-04-15, From 2024-01-01
2023-12-31-$3.77n/m2025-04-15, From 2023-01-01
2022-12-31-$3.13n/a2024-02-20, From 2022-01-01